Beximco in milestone achievement with Kuwait exports

17 June 2016

Beximco has notched up another milestone by becoming the first Bangladeshi pharma company to launch pharmaceutical products in any Gulf member country by starting to export to Kuwait.

The manufacturer of generic pharmaceutical products and active pharmaceutical ingredients has started exporting to the country under the Cooperation Council for the Arab States of the Gulf (GCC) economic union.

A launch ceremony was held at Beximco Pharma’s factory in Dhaka to mark the shipment of the first consignment in the presence of the Ambassador of Kuwait, Adel Mohammad Hayat.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK